Am. J. Respir. Crit. Care Med.,
Volume 162, Number 3, September 2000, 1120-1122
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
W. Matsuyama, H. Mitsuyama, M. Ono, Y. Shirahama, I. Higashimoto, M. Osame, and K. Arimura Discoidin domain receptor 1 contributes to eosinophil survival in an NF-{kappa}B-dependent manner in Churg-Strauss syndrome Blood, January 1, 2007; 109(1): 22 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Matsuyama, M. Watanabe, Y. Shirahama, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura Discoidin Domain Receptor 1 Contributes to the Survival of Lung Fibroblast in Idiopathic Pulmonary Fibrosis Am. J. Pathol., March 1, 2006; 168(3): 866 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mitsuyama, W. Matsuyama, J. Iwakawa, I. Higashimoto, M. Watanabe, M. Osame, and K. Arimura Increased serum vascular endothelial growth factor level in churg-strauss syndrome. Chest, February 1, 2006; 129(2): 407 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Matsuyama, M. Watanabe, Y. Shirahama, R. Hirano, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation J. Immunol., February 1, 2006; 176(3): 1928 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Matsuyama, H. Mitsuyama, M. Watanabe, Y. Shirahama, I. Higashimoto, M. Osame, and K. Arimura Involvement of Discoidin Domain Receptor 1 in the Deterioration of Pulmonary Sarcoidosis Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Matsuyama, M. Watanabe, Y. Shirahama, K.-i. Oonakahara, I. Higashimoto, T. Yoshimura, M. Osame, and K. Arimura Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Pulmonary Fibrosis J. Immunol., May 15, 2005; 174(10): 6490 - 6498. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Arena, S. Ferrero, F. Alatas, O. Alatas, M. Metintas, A. Ozarslan, S. Erginel, and H. Yildirim Is Measurement of Serum Vascular Endothelial Growth Factor Reliable in Patients With Active Pulmonary Tuberculosis? Chest, February 1, 2005; 127(2): 686 - 687. [Full Text] [PDF] |
||||
![]() |
F. Alatas, O. Alatas, M. Metintas, A. Ozarslan, S. Erginel, and H. Yildirim Vascular Endothelial Growth Factor Levels in Active Pulmonary Tuberculosis Chest, June 1, 2004; 125(6): 2156 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Oonakahara, W. Matsuyama, I. Higashimoto, M. Kawabata, K. Arimura, and M. Osame Stromal-Derived Factor-1{alpha}/CXCL12-CXCR 4 Axis Is Involved in the Dissemination of NSCLC Cells into Pleural Space Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SCHULZ, C. HUMMEL, S. HEINEMANN, W. SEEGER, and F. GRIMMINGER Serum Levels of Vascular Endothelial Growth Factor Are Elevated in Patients with Obstructive Sleep Apnea and Severe Nighttime Hypoxia Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 67 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |